Bioinformatic interrogation of ZNF582-AS1 signatures in transcriptome and methylome suggests that ZNF582-AS1 may suppress tumor cell proliferation and viability and promote apoptosis via inhibition of the HER2-related signaling pathway. This evidence concerns the gene ERBB2 and neoplasm.